Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CHLORTETRACYCLINE HYDROCHLORIDE PH.EUR. (EQUIVALENT TO 2.45% W/W)
Eurovet Animal Health B.V.
QD06A
CHLORTETRACYCLINE HYDROCHLORIDE PH.EUR. (EQUIVALENT TO 2.45% W/W)
2.45 %w/w
Cutaneous Spray, suspension
POM
Bovine, Ovine, Porcine
ANTIBIOTICS FOR TOPICAL USE
Antibacterial
Authorised
2001-03-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Cyclo Spray, 2.45 % w/w for cattle, sheep and pigs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Cutaneous Spray, Suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, sheep and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES • Treatment of superficial traumatic or surgical wounds contaminated with chlortetracycline-sensitive agents. • The product can be used as part of a treatment for superficial skin and claw/hoof infections, in particular interdigital dermatitis (foot rot and foul in the foot) and digital dermatitis caused by micro-organisms sensitive to chlortetracycline. Per container of 270 mL: ACTIVE SUBSTANCE: Chlortetracycline HCl. The active ingredient content is 2.45 % w/w (equivalent to 3.210 g) EXCIPIENTS: Patent Blue V (E 131) 0.15 % w/w (equivalent to 0.196 g) Butane 100 68.77% w/w(equivalent to 89.920g) Per container of 520 mL: ACTIVE SUBSTANCE: Chlortetracycline HCl. The active ingredient content is 2.45 % w/w (equivalent to 6.420 g) EXCIPIENTS: Patent Blue V (E 131) 0.15 % w/w (equivalent to 0.392 g) Butane 100 68.77%w/w(equivalent to 179.840g) For a full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _5_ _/_ _0_ _1_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _5_ _4_ _9_ _4_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to tetr Read the complete document